Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Key Considerations In The Timing Of FCPA Violation Disclosures
Will COVID-19 “Crony Charities” Trigger the Next Wave of FCPA Fumbles?
Pandemic May Not Boost FCPA Enforcement
SEC’s Recent FCPA Complaint May Reveal Benefits of Company Compliance but Pleadings May Be Deficient
Alexion Pharmaceuticals Strikes Tentative $25 Million Bribery Settlement
DOJ Declinations under FCPA Corporate Enforcement Policy
Antibribery Compliance Has to Continue, Officials Say
SEC Examinations and Enforcement in the COVID-19 Era
Recidivist Eni: Corruption, Controls, and Books and Records
Keeping Track of Current Events for Continuous Improvement
Um, About That Goldman FCPA Case…
Eni Settles FCPA Case and SEC Files Case Against Ex-Goldman Sachs Executive
Top 10 International Anti-Corruption Developments for March 2020
FCPA Landmines Beneath the Surface of the COVID-19 Crisis
Top 10 International Anti-Corruption Developments for February 2020
Judge Grants FCPA Defendants Baptiste and Boncy New Trials
Practice Alert: Is Every Email Another FCPA Violation?
Defendants Cannot Show that CMS Guidance Allows for Reimbursement of Travel that Never Occurred; United States Court of Appeals for the Fifth Circuit No. 18-20501. U.S. ex rel. Richard Drummond v. BestCare Laboratory Services L.L.C. and Karim A. Maghareh
Herbalife Sets Aside $40 Million for Bribery Settlement
Keep reading
